LTRN
Price:
$3.79
Market Cap:
$48.36M
Lantern Pharma Inc. is a clinical-stage biotechnology firm dedicated to revolutionizing drug development through the strategic application of artificial intelligence, machine learning, and comprehensive genomic data analysis. Their primary drug candidate, LP-100, is currently undergoing Phase II clinical trials, targeting metastatic, castration-resistant prostate cancer. The company is also advancing LP-300 as a potential combination therapy for non-small cell lung cancer adenocarcinoma, specifically in individuals who are non-smokers or have never smoked. Furthermore, their preclinical pipeline includes LP-184, an alkylating agent engineered to inflict DNA damage upon cancer cells that eith...[Read more]
Industry
Biotechnology
IPO Date
2020-06-11
Stock Exchange
NASDAQ
Ticker
LTRN
According to Lantern Pharma Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.87. This represents a change of -32.81% compared to the average of 2.78 of the last 4 quarters.
The mean historical Current Ratio of Lantern Pharma Inc. over the last ten years is 14.56. The current 1.87 Current Ratio has changed 1.18% with respect to the historical average. Over the past ten years (40 quarters), LTRN's Current Ratio was at its highest in in the March 2021 quarter at 124.12. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
14.56
Median
11.01
Minimum
0.68
Maximum
36.64
Discovering the peaks and valleys of Lantern Pharma Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.35%
Maximum Annual Current Ratio = 36.64
Minimum Annual Increase = -63.98%
Minimum Annual Current Ratio = 0.68
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 2.40 | -58.83% |
| 2024 | 5.83 | -63.98% |
| 2023 | 16.18 | -22.88% |
| 2022 | 20.99 | -32.87% |
| 2021 | 31.26 | -14.68% |
| 2020 | 36.64 | 1.35% |
| 2019 | 2.52 | 268.82% |
The current Current Ratio of Lantern Pharma Inc. (LTRN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.14
5-year avg
15.33
10-year avg
14.56
Lantern Pharma Inc.’s Current Ratio is less than Elutia Inc. (2.05), less than Tvardi Therapeutics, Inc. (2.25), greater than CalciMedica, Inc. (1.61), less than MAIA Biotechnology, Inc. (5.59), less than LAVA Therapeutics N.V. (12.27), less than RenovoRx, Inc. (7.15), less than Reviva Pharmaceuticals Holdings, Inc. (3.85), less than Actinium Pharmaceuticals, Inc. (5.89), greater than Annovis Bio, Inc. (1.27), greater than BioAtla, Inc. (0.15),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.05 | $46.86M | |
| 2.25 | $24.67M | |
| 1.61 | $11.93M | |
| 5.59 | $85.12M | |
| 12.27 | $45.77M | |
| 7.15 | $34.25M | |
| 3.85 | $2.08M | |
| 5.89 | $32.32M | |
| 1.27 | $34.43M | |
| 0.15 | $4.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantern Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lantern Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Lantern Pharma Inc.'s Current Ratio?
How is the Current Ratio calculated for Lantern Pharma Inc. (LTRN)?
What is the highest Current Ratio for Lantern Pharma Inc. (LTRN)?
What is the 3-year average Current Ratio for Lantern Pharma Inc. (LTRN)?
What is the 5-year average Current Ratio for Lantern Pharma Inc. (LTRN)?
How does the current Current Ratio for Lantern Pharma Inc. (LTRN) compare to its historical average?